157 related articles for article (PubMed ID: 29909377)
1. Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled Trial.
Okada S; Morimoto T; Ogawa H; Sakuma M; Matsumoto C; Soejima H; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Saito Y;
Diabetes Care; 2018 Aug; 41(8):1757-1764. PubMed ID: 29909377
[TBL] [Abstract][Full Text] [Related]
2. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.
Saito Y; Okada S; Ogawa H; Soejima H; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Morimoto T;
Circulation; 2017 Feb; 135(7):659-670. PubMed ID: 27881565
[TBL] [Abstract][Full Text] [Related]
3. Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes.
Okada S; Morimoto T; Ogawa H; Soejima H; Matsumoto C; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Saito Y
J Gen Intern Med; 2021 Mar; 36(3):632-639. PubMed ID: 33063203
[TBL] [Abstract][Full Text] [Related]
4. Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical Trial.
Matsumoto C; Ogawa H; Saito Y; Okada S; Soejima H; Sakuma M; Masuda I; Nakayama M; Doi N; Jinnouchi H; Waki M; Morimoto T; ;
Diabetes Care; 2020 Feb; 43(2):314-320. PubMed ID: 31801787
[TBL] [Abstract][Full Text] [Related]
5. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
Ogawa H; Nakayama M; Morimoto T; Uemura S; Kanauchi M; Doi N; Jinnouchi H; Sugiyama S; Saito Y;
JAMA; 2008 Nov; 300(18):2134-41. PubMed ID: 18997198
[TBL] [Abstract][Full Text] [Related]
6. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
[TBL] [Abstract][Full Text] [Related]
7. Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study.
Okada S; Morimoto T; Ogawa H; Sakuma M; Soejima H; Nakayama M; Jinnouchi H; Waki M; Akai Y; Ishii H; Saito Y;
PLoS One; 2016; 11(1):e0147635. PubMed ID: 26808136
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women.
Pradhan AD; Cook NR; Manson JE; Ridker PM; Buring JE
Diabetes Care; 2009 Jan; 32(1):3-8. PubMed ID: 18835953
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: a subanalysis of the JPAD trial.
Okada S; Morimoto T; Ogawa H; Kanauchi M; Nakayama M; Uemura S; Doi N; Jinnouchi H; Waki M; Soejima H; Sakuma M; Saito Y;
Diabetes Care; 2011 Jun; 34(6):1277-83. PubMed ID: 21515838
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.
Lee IM; Cook NR; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
JAMA; 2005 Jul; 294(1):56-65. PubMed ID: 15998891
[TBL] [Abstract][Full Text] [Related]
11. Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial.
Soejima H; Ogawa H; Morimoto T; Nakayama M; Okada S; Uemura S; Kanauchi M; Doi N; Sakuma M; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
Circ J; 2012; 76(6):1526-32. PubMed ID: 22447019
[TBL] [Abstract][Full Text] [Related]
12. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial.
Cook NR; Lee IM; Zhang SM; Moorthy MV; Buring JE
Ann Intern Med; 2013 Jul; 159(2):77-85. PubMed ID: 23856681
[TBL] [Abstract][Full Text] [Related]
13. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
[TBL] [Abstract][Full Text] [Related]
14. Association of Long-term Use of Low-Dose Aspirin as Chemoprevention With Risk of Lung Cancer.
Ye S; Lee M; Lee D; Ha EH; Chun EM
JAMA Netw Open; 2019 Mar; 2(3):e190185. PubMed ID: 30821825
[TBL] [Abstract][Full Text] [Related]
15. Proteinuria is independently associated with the incidence of primary cardiovascular events in diabetic patients.
Soejima H; Ogawa H; Morimoto T; Okada S; Matsumoto C; Nakayama M; Masuda I; Jinnouchi H; Waki M; Saito Y;
J Cardiol; 2020 Apr; 75(4):387-393. PubMed ID: 31564388
[TBL] [Abstract][Full Text] [Related]
16. Low-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trial.
Saito Y; Morimoto T; Ogawa H; Nakayama M; Uemura S; Doi N; Jinnouchi H; Waki M; Soejima H; Sugiyama S; Okada S; Akai Y;
Diabetes Care; 2011 Feb; 34(2):280-5. PubMed ID: 21270185
[TBL] [Abstract][Full Text] [Related]
17. Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus.
Matsumoto C; Ogawa H; Saito Y; Okada S; Soejima H; Sakuma M; Masuda I; Nakayama M; Doi N; Jinnouchi H; Waki M; Morimoto T
BMJ Open Diabetes Res Care; 2022 Mar; 10(2):. PubMed ID: 35361621
[TBL] [Abstract][Full Text] [Related]
18. Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study.
Ong G; Davis TM; Davis WA
Diabetes Care; 2010 Feb; 33(2):317-21. PubMed ID: 19918016
[TBL] [Abstract][Full Text] [Related]
19. One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus.
Soejima H; Ogawa H; Morimoto T; Okada S; Sakuma M; Nakayama M; Masuda I; Doi N; Uemura S; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
J Cardiol; 2019 Jan; 73(1):33-37. PubMed ID: 30487058
[TBL] [Abstract][Full Text] [Related]
20. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.
Cook NR; Lee IM; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
JAMA; 2005 Jul; 294(1):47-55. PubMed ID: 15998890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
